STEQEYMA 130 mg/26mL
ustekinumab-stba · INJECTION, SOLUTION · CELLTRION USA, Inc.
No Recall History
Plain English
STEQEYMA is a injection, solution containing ustekinumab-stba at 130 mg/26mL, taken intravenous. Manufactured by CELLTRION USA, Inc..
Key Facts
- Brand Name
- STEQEYMA
- Generic Name
- ustekinumab-stba
- NDC Code (Product)
72606-029- Manufacturer
- CELLTRION USA, Inc.
- Strength
- 130 mg/26mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761338
- Drug Class
- Interleukin-12 Antagonist [EPC]; Interleukin-23 Antagonist [EPC]
- Marketing Start
- 03/12/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is STEQEYMA used for?
STEQEYMA contains ustekinumab-stba. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is STEQEYMA a controlled substance?
STEQEYMA is not classified as a controlled substance by the DEA.
What is the generic name for STEQEYMA?
The generic name for STEQEYMA is ustekinumab-stba. There are no other listed brand versions of ustekinumab-stba.
What is the NDC code for STEQEYMA 130 mg/26mL?
The NDC (National Drug Code) for STEQEYMA 130 mg/26mL is 72606-029, listed by CELLTRION USA, Inc..
Other STEQEYMA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)